BridgeMD
New treatment option for Neuropathy
Official title Balance Rehabilitation With Modified Visual Input in Patients With Neuropathy
ClinicalTrials.gov ID: NCT03881930
What this study is testing
- What it's testing
- This research focuses on the effects of rehabilitation on balance, in patients with acquired chronic demyelinating neuropathy. Rehabilitation will be performed with or without vision.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients with chronic demyelinating acquired neuropathy
- Age ≥ 18 years.
- Patients able to walk 20 meters without human assistance at least indoors with or without technical assistance.
- Patients with complaints such as discomfort, walking instability related to sensitivity disorders.
- Patients being clinically stable for at least 2 months, regardless of ongoing treatments.
You likely can't join if
- Patients unable to walk 20 metres without technical and human assistance indoors.
- Patients with an ongoing hospitalization.
- Patients already included and participating in another intervention study.
- Patients with ongoing balance rehabilitation and continued during the REQ-PRO program in another rehabilitation centre or practice.
- Patients with ongoing acute treatment (related to polyneuropathy) started less than 2 months ago or stopped less than 2 months ago.
- Patients with scheduled surgery during the period of the patient's participation in the protocol, preventing the successful completion of the...
See the full eligibility criteria
- Patients with chronic demyelinating acquired neuropathy
- Age ≥ 18 years.
- Patients able to walk 20 meters without human assistance at least indoors with or without technical assistance.
- Patients with complaints such as discomfort, walking instability related to sensitivity disorders.
- Patients being clinically stable for at least 2 months, regardless of ongoing treatments.
- Patients who have provided consent.
- Patients unable to walk 20 metres without technical and human assistance indoors.
- Patients with an ongoing hospitalization.
- Patients already included and participating in another intervention study.
- Patients with ongoing balance rehabilitation and continued during the REQ-PRO program in another rehabilitation centre or practice.
- Patients with ongoing acute treatment (related to polyneuropathy) started less than 2 months ago or stopped less than 2 months ago.
- Patients with scheduled surgery during the period of the patient's participation in the protocol, preventing the successful completion of the rehabilitation program and participation in assessments.
- Patients with recent surgery, in particular lower limb prosthesis (less than 1 year old) or equipment contraindicated for planned exercises such as standing kneeling positions.
- Patients with skin wounds on the foot that contraindicate rehabilitation.
- Patients with balance disorders of vestibular origin or central neurological pathology.
- Patients with a visual disability.
- Patients with a hearing impairment that prevents the patient from hearing and understanding instructions during the rehabilitation program or assessments.
- Patients with an inability to speak or understand the French language.
- Patients with cognitive or language impairments that prevent understanding of the protocol.
- Patients with a residence outside of the Paris Region (Ile de France).
- Patients with a known pregnancy.
- Patients not affiliated to a social security system (beneficiary or having a right), deprived of their right, under guardianship, curatorship, prisoner.
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.